These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 17078868)
21. The N-terminus of the WD5 repeat of human RACK1 binds to airway epithelial NHERF1. Liedtke CM; Wang X Biochemistry; 2006 Aug; 45(34):10270-7. PubMed ID: 16922502 [TBL] [Abstract][Full Text] [Related]
22. Human epidermal growth factor receptor 2, Na+/H+ exchanger regulatory factor 1, and breast cancer susceptibility gene-1 as new biomarkers for familial breast cancers. Mangia A; Malfettone A; Saponaro C; Tommasi S; Simone G; Paradiso A Hum Pathol; 2011 Nov; 42(11):1589-95. PubMed ID: 21496870 [TBL] [Abstract][Full Text] [Related]
24. Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function. Kreimann EL; Morales FC; de Orbeta-Cruz J; Takahashi Y; Adams H; Liu TJ; McCrea PD; Georgescu MM Oncogene; 2007 Aug; 26(36):5290-9. PubMed ID: 17325659 [TBL] [Abstract][Full Text] [Related]
25. Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. Shu ST; Sugimoto Y; Liu S; Chang HL; Ye W; Wang LS; Huang YW; Yan P; Lin YC Anticancer Res; 2010 Jun; 30(6):1937-46. PubMed ID: 20651337 [TBL] [Abstract][Full Text] [Related]
26. Functional importance of PP2A regulatory subunit loss in breast cancer. Watt LF; Panicker N; Mannan A; Copeland B; Kahl RGS; Dun MD; Young B; Roselli S; Verrills NM Breast Cancer Res Treat; 2017 Nov; 166(1):117-131. PubMed ID: 28744751 [TBL] [Abstract][Full Text] [Related]
27. TOB suppresses breast cancer tumorigenesis. O'Malley S; Su H; Zhang T; Ng C; Ge H; Tang CK Int J Cancer; 2009 Oct; 125(8):1805-13. PubMed ID: 19569230 [TBL] [Abstract][Full Text] [Related]
28. NHERF1 regulates actin cytoskeleton organization through modulation of α-actinin-4 stability. Sun L; Zheng J; Wang Q; Song R; Liu H; Meng R; Tao T; Si Y; Jiang W; He J FASEB J; 2016 Feb; 30(2):578-89. PubMed ID: 26432781 [TBL] [Abstract][Full Text] [Related]
29. β1, β2, and β3 adrenoceptors and Na+/H+ exchanger regulatory factor 1 expression in human bronchi and their modifications in cystic fibrosis. Bossard F; Silantieff E; Lavazais-Blancou E; Robay A; Sagan C; Rozec B; Gauthier C Am J Respir Cell Mol Biol; 2011 Jan; 44(1):91-8. PubMed ID: 20203292 [TBL] [Abstract][Full Text] [Related]
31. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2. Jeong J; VanHouten JN; Kim W; Dann P; Sullivan C; Choi J; Sneddon WB; Friedman PA; Wysolmerski JJ J Biol Chem; 2017 Apr; 292(16):6555-6568. PubMed ID: 28235801 [TBL] [Abstract][Full Text] [Related]
32. The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea. Simpson N; Shaw R; Crepin VF; Mundy R; FitzGerald AJ; Cummings N; Straatman-Iwanowska A; Connerton I; Knutton S; Frankel G Mol Microbiol; 2006 Apr; 60(2):349-63. PubMed ID: 16573685 [TBL] [Abstract][Full Text] [Related]
33. Targeting of Ma Q; Jiao Y; Hao Y; Yan S; Lyu N; Gao H; Li D; Liu Q; Zheng J; Song N Oncol Lett; 2016 Feb; 11(2):1149-1154. PubMed ID: 26893710 [TBL] [Abstract][Full Text] [Related]
34. Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells. Nilsson EM; Brokken LJ; Narvi E; Kallio MJ; Härkönen PL Mol Cell Endocrinol; 2012 Jul; 358(1):104-15. PubMed ID: 22465097 [TBL] [Abstract][Full Text] [Related]
35. NHERF1: molecular brake on the PI3K pathway in breast cancer. Georgescu MM Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260 [TBL] [Abstract][Full Text] [Related]
36. NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma. Georgescu MM; Yell P; Mobley BC; Shang P; Georgescu T; Wang SH; Canoll P; Hatanpaa KJ; White CL; Raisanen JM Acta Neuropathol Commun; 2015 Mar; 3():11. PubMed ID: 25775275 [TBL] [Abstract][Full Text] [Related]
37. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone. Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer. Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513 [TBL] [Abstract][Full Text] [Related]
39. PRL-3 Promotes the Malignant Progression of Melanoma via Triggering Dephosphorylation and Cytoplasmic Localization of NHERF1. Fang XY; Song R; Chen W; Yang YY; Gu YH; Shu YQ; Wu XD; Wu XF; Sun Y; Shen Y; Xu Q J Invest Dermatol; 2015 Sep; 135(9):2273-2282. PubMed ID: 25897829 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of p27Kip1 inhibits the growth of both normal and transformed human mammary epithelial cells. Sgambato A; Zhang YJ; Ciaparrone M; Soh JW; Cittadini A; Santella RM; Weinstein IB Cancer Res; 1998 Aug; 58(15):3448-54. PubMed ID: 9699679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]